Tilray | TRLY - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurora Cannabis CAD 230K 1.88M 2026-03
Avita Medical AUD 1.25M 100K 2025-06
Canopy Growth CAD 12.31M 4.97M 2026-03
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Moderna USD 11.49B 36B 2026-03
Organigram Holdings CAD 179K 127K 2025-03
Organon & Co USD 111M 17M 2026-03
Revvity USD 24.72M 1.2M 2026-03
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 6.88M 269K 2026-03
Zealand Pharma A/S 7.07M 74K 2025-12